Artificial Intelligence
Global Bioprocess Validation Market to Reach $622.6 Million by 2030
<!– Name:DistributionId Value:8750842 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1199811 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:1e48a693-ce4d-4abe-b08e-382d5d48379c –>
New York, Feb. 16, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Bioprocess Validation Industry” – https://www.reportlinker.com/p06030939/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Bioprocess Validation Market to Reach $622.6 Million by 2030
In the changed post COVID-19 business landscape, the global market for Bioprocess Validation estimated at US$329.9 Million in the year 2022, is projected to reach a revised size of US$622.6 Million by 2030, growing at a CAGR of 8.3% over the analysis period 2022-2030. Extractables / Leachables Testing Services, one of the segments analyzed in the report, is projected to record a 9% CAGR and reach US$255.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Integrity Testing Services segment is readjusted to a revised 8.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $121.7 Million, While China is Forecast to Grow at 11.4% CAGR
The Bioprocess Validation market in the U.S. is estimated at US$121.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$80.8 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 7.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.
Select Competitors (Total 50 Featured)
– Almac Group
– Biozeen
– Cobetter Filtration Equipment Co., Ltd.
– Doc S.R.L.
– Eurofins Scientific
– Hangzhou Anow Microfiltration Co., Ltd.
– Meissner Filtration Products, Inc.
– Merck KGaA
– Pall Corporation (A Part of Danaher Corporation)
– Porvair PLC
Read the full report: https://www.reportlinker.com/p06030939/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and the Global Economic Update
War & Inflation Supersede COVID-19 as Major Downside Risks for
the Global Economy in 2023 & Beyond
Here?s How Inflationary Pressures Affect the Economy
Russia-Ukraine War, the Primary Culprit Responsible for the
Hardships
Stubbornly High Inflation to Single Handedly Drag Down Global
Growth
Growt
EXHIBIT 1: Shaken by the War, Global Oil Prices Spiral and Feed
Inflationary Pressures, Guiding the World towards a Cost of
Living Crisis: Global Average Annual Brent Crude Oil Price:
(In US$ Per Barrel) for Years 2017 through 2023
EXHIBIT 2: War-Induced Commodity Price Increases & Broad Based
Price Pressures Mark the Return of Global Inflation in 2022 to
the Highest Level Seen Since 1996: Global Inflation Rates (In
%) for the Years 2019 Through 2024
EXHIBIT 3: War, Global Inflation, Cost of Living Crisis, Failed
Fiscal Policy Attempts to Restore Price Stability & Contain
Downside Risks to Result in Sharper-Than-Expected Slowdown in
Global Economic Growth: World Economic Growth Projections:
(Real GDP, Annual % Change) for the Years 2020, 2021, 2022
and 2023
EXHIBIT 4: Recession Triggered by Uncontrolled Inflation or
Unemployment, Which is the Greater Evil? Inflation Battling
Policy Measures to Slowdown Post Pandemic Recovery in
Unemployment Rates: Global Number of Unemployed People (In
Million) for Years 2019 Through 2023
Pandemic Impact on Bioprocess Validation Market
An Introduction to Bioprocess Validation
Types of Process Validation
Global Market Outlook
Extractables/Leachables Testing Services: The Largest Segment
Developed Regions Lead, Developing Economies Promise Future Growth
Competition
EXHIBIT 5: Bioprocess Validation – Global Key Competitors
Percentage Market Share in 2023 (E)
Competitive Market Presence – Strong/Active/Niche for Players
Worldwide in 2023 (E)
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rapid Growth in Biopharmaceutical Production and Need to
Prevent Product Contamination Necessitate Validation Services
EXHIBIT 6: Global Biopharmaceuticals Market in US$ Billion for
the Years 2022, 2024, 2026 and 2028
Increasing Pharma & Biotech Investments into Drug Development
Activities Fuel Need for Bioprocess Validation
EXHIBIT 7: Pharmaceutical R&D Spending Worldwide (USD Billion)
for 2015-2025
Rise of Pharma Contract Manufacturing Present Growth
Opportunities for Bioprocess Validation Outsourcing to
Emerging Markets
EXHIBIT 8: Global Pharmaceutical Contract Manufacturing Market
by Geographic Region for 2021 and 2027
Biosimilars Gain from Patent Expiry of Major Drugs, Driving
Gains for Bioprocess Validation Market
Strict Safety & Quality Regulations and Compliance with cGMP
for Biopharmaceuticals Support Market Growth
Bioprocessing 4.0: Implications for Bioprocess Validation
Validation 4.0: Essential for Sciences Industry Progresses
towards Digital-First Industry
Growing Prominence of Paperless Validation in Pharma, Biotech &
Medical Devices Industries
Bioprocess Innovations Direct Focus onto Effective & Clear
Validations
Digital Twins to Support Bioprocess Validation Market Growth
AI-Enabled System-Led Transformations in Biomanufacturing &
Bioprocess Validation
Artificial Intelligence and Continuous Validation
Single-Use Disposable Technologies Gain Attention
Bioprocess Data: Critical for Improving Efficiency of Pharma
Developments & Manufacturing Operations
Advancing Process Analytical Technologies Necessitates Validation
Process Validation for Viral Vectors: What are the Key Challenges?
Aging Population & Increasing Burden of Chronic Diseases Spurs
Pharma Product Sales, Driving Market Growth
EXHIBIT 9: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 10: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 11: World Diabetes and Population Statistics (2019,
2030 & 2045)
EXHIBIT 12: Fatalities by Heart Conditions – Estimated
Percentage Breakdown for Cardiovascular Disease, Ischemic
Heart Disease, Stroke, and Others
Challenges Confronting Bioprocess Validation
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Bioprocess Validation Market Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for
Bioprocess Validation by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2022 through 2030 and % CAGR
Table 3: World Historic Review for Bioprocess Validation by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 4: World 16-Year Perspective for Bioprocess Validation by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for
Extractables / Leachables Testing Services by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Thousand for Years 2022 through 2030
and % CAGR
Table 6: World Historic Review for Extractables / Leachables
Testing Services by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2014 through 2021 and % CAGR
Table 7: World 16-Year Perspective for Extractables /
Leachables Testing Services by Geographic Region – Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa for
Years 2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Integrity Testing Services by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for Integrity Testing Services
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 10: World 16-Year Perspective for Integrity Testing
Services by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 11: World Recent Past, Current & Future Analysis for
Microbiological Testing Services by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Microbiological Testing
Services by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2014 through 2021 and % CAGR
Table 13: World 16-Year Perspective for Microbiological Testing
Services by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 14: World Recent Past, Current & Future Analysis for
Compatibility Testing Services by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Compatibility Testing
Services by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2014 through 2021 and % CAGR
Table 16: World 16-Year Perspective for Compatibility Testing
Services by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 17: World Recent Past, Current & Future Analysis for
Other Test Types by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Other Test Types by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Other Test Types by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Pharmaceutical Companies by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Pharmaceutical Companies by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Pharmaceutical
Companies by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 23: World Recent Past, Current & Future Analysis for
Biotechnology Companies by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Biotechnology Companies by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Biotechnology Companies
by Geographic Region – Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Contract Development & Manufacturing Organizations by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Contract Development &
Manufacturing Organizations by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Contract Development &
Manufacturing Organizations by Geographic Region – Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa for
Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 31: World 16-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Bioprocess Validation Market Presence – Strong/Active/Niche –
Key Competitors in the United States for 2023 (E)
Market Analytics
Table 32: USA Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Bioprocess Validation by Test
Type – Extractables / Leachables Testing Services, Integrity
Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 34: USA 16-Year Perspective for Bioprocess Validation by
Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 35: USA Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 36: USA Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: USA 16-Year Perspective for Bioprocess Validation by
End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 40: Canada 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 41: Canada Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 42: Canada Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 43: Canada 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
JAPAN
Table 44: Japan Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 45: Japan Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 46: Japan 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 47: Japan Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 48: Japan Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: Japan 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
CHINA
Table 50: China Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 51: China Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 52: China 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 53: China Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 54: China Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 55: China 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
EUROPE
Bioprocess Validation Market Presence – Strong/Active/Niche –
Key Competitors in Europe for 2023 (E)
Market Analytics
Table 56: Europe Recent Past, Current & Future Analysis for
Bioprocess Validation by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR
Table 57: Europe Historic Review for Bioprocess Validation by
Geographic Region – France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets – Independent Analysis of Annual
Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: Europe 16-Year Perspective for Bioprocess Validation
by Geographic Region – Percentage Breakdown of Value Revenues
for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2014, 2023 & 2030
Table 59: Europe Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 61: Europe 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 62: Europe Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 63: Europe Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 64: Europe 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
FRANCE
Table 65: France Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 66: France Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 67: France 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 68: France Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 69: France Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 70: France 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
GERMANY
Table 71: Germany Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 72: Germany Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 73: Germany 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 74: Germany Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 75: Germany Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: Germany 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
ITALY
Table 77: Italy Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 78: Italy Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 79: Italy 16-Year Perspective for Bioprocess Validation
by Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 80: Italy Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 81: Italy Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: Italy 16-Year Perspective for Bioprocess Validation
by End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
UNITED KINGDOM
Table 83: UK Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 84: UK Historic Review for Bioprocess Validation by Test
Type – Extractables / Leachables Testing Services, Integrity
Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 85: UK 16-Year Perspective for Bioprocess Validation by
Test Type – Percentage Breakdown of Value Revenues for
Extractables / Leachables Testing Services, Integrity Testing
Services, Microbiological Testing Services, Compatibility
Testing Services and Other Test Types for the Years 2014, 2023 &
2030
Table 86: UK Recent Past, Current & Future Analysis for
Bioprocess Validation by End-Use – Pharmaceutical Companies,
Biotechnology Companies, Contract Development & Manufacturing
Organizations and Other End-Uses – Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR
Table 87: UK Historic Review for Bioprocess Validation by
End-Use – Pharmaceutical Companies, Biotechnology Companies,
Contract Development & Manufacturing Organizations and Other
End-Uses Markets – Independent Analysis of Annual Revenues in
US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: UK 16-Year Perspective for Bioprocess Validation by
End-Use – Percentage Breakdown of Value Revenues for
Pharmaceutical Companies, Biotechnology Companies, Contract
Development & Manufacturing Organizations and Other End-Uses
for the Years 2014, 2023 & 2030
SPAIN
Table 89: Spain Recent Past, Current & Future Analysis for
Bioprocess Validation by Test Type – Extractables / Leachables
Testing Services, Integrity Testing Services, Microbiological
Testing Services, Compatibility Testing Services and Other Test
Types – Independent Analysis of Annual Revenues in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 90: Spain Historic Review for Bioprocess Validation by
Test Type – Extractables / Leachables Testing Services,
Integrity Testing Services, Microbiological Testing Services,
Compatibility Testing Services and Other Test Types Markets –
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2014 through 2021 and % CAGR
Table 91: Spain 16-Year Perspective for Bioprocess Validation
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06030939/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
Cayman Enterprise City Publishes Socio-Economic Impact Assessment by Economist and Leading Advisor on the Caribbean, Marla Dukharan
The Impact of Cayman Enterprise City’s Socio-Economic Development Project Nears USD $1 Billion
GRAND CAYMAN, Cayman Islands, May 16, 2024 /PRNewswire/ — Cayman Enterprise City (CEC) has released a Socio-Economic Impact Assessment by Marla Dukharan. The report illustrates that CEC is increasing its impact by supporting higher earnings for Caymanians and is driving a shift towards a knowledge-based economy by focusing on high productivity sectors. The release by Dukharan reads, “Caymanian resourcefulness and private sector-led innovation have been the driving force behind the islands’ outstanding socio-economic success. Cayman Enterprise City underpins the next generation of Cayman innovation and dynamism.”
With an economic impact of USD $130 million in 2023, contributing just under USD $1 billion to the local economic activity in 12 years since inception, “CEC is helping the nation to diversify economically, in terms of sectors and jobs, ensuring locals have economic and employment opportunities that match the nation’s progress,” the report reads.
The CEC socio-economic development project is now home to 352 Special Economic Zones Companies (SEZCos), many of which are globally recognised institutions led by top executives and industry experts. “CEC member companies are providing high-value employment with salaries exceeding those typically found outside of the special economic zone,” said Charlie Kirkconnell, Chief Executive Officer at CEC. “The CEC community is fully invested in Cayman and the report illustrates that the CEC socio-economic development project is making a very significant impact on Cayman’s economy and community.”
“As CEC continues to grow, it continues to create significant employment and entrepreneurial opportunities for Caymanians and we encourage anyone that might be interested in finding out how they might get involved, whether as a member of the community and/or as a volunteer in our Enterprise Cayman non-profit organisation (NPO).”
77% of Caymanian-held jobs at CEC member companies, are in sectors with high social returns and increasing global demand. “By putting skills first and prioritizing learning, CEC is enabling new industries to take root,” the release by Dukharan reads.
CEC, through its Enterprise Cayman NPO, is a first-mover in private sector-facilitated education and training in the Caribbean, making it a leading force to boost youth participation in the economy. By offering training in specialised skills, Enterprise Cayman is helping to close the gap in higher education and earnings for Caymanians. “Through Enterprise Cayman we’ve set out to strategically support meaningful employment and entrepreneurial opportunities for Caymanians, by providing internship and mentorship opportunities, by hosting skill-building and career focused training, and by providing invaluable networking and community engagement opportunities,” said Kirkconnell.
In 2023 individuals took advantage of 4,226 opportunities to participate in education, training, and career development events and, since launching entrepreneurial programming in 2021, Enterprise Cayman has worked with 41 new Cayman-born business ventures. “We’re helping to develop a local talent pool that meets the demand of Cayman’s growing digital innovation and technology sectors while, in parallel, offering exciting opportunities for individuals to launch new business ventures within an innovative business environment,” said Kirkconnell.
With CEC’s new campus and state-of-the-art facilities, Signal House, the project “holds the promise of deep, continued economic impact,” the report concludes.
To access CEC’s economic impact assessments and Enterprise Cayman’s annual reports please visit https://www.enterprisecayman.ky/reports. For more information on how to get involved and for upcoming programmes and events visit www.enterprisecayman.ky.
Website: www.caymanenterprisecity.com LinkedIn: @CaymanEnterpriseCityTwitter: @CEC_CaymanInstagram: @CaymanEnterpriseCityFacebook: @CaymanEnterpriseCityYouTube: @ceccayman
About Cayman Enterprise City
Cayman Enterprise City (CEC) is an award-winning development project which consists of three special economic zones (SEZs) focused on attracting knowledge-based and specialised-services businesses to set up a genuine physical presence in the Cayman Islands. The zones included within CEC are Cayman Tech City, Cayman Commodities & Derivatives Centre, and Cayman Maritime & Aviation City. With a dedicated Government Authority, licensing fee concessions and guaranteed fast-track processes, CEC enables international companies to quickly and efficiently establish a Cayman Islands office, which in turn enables them to generate active business income within a tax neutral environment.
About Enterprise Cayman
Enterprise Cayman is a non-profit organisation (NPO) powered by Cayman Enterprise City in partnership with Cayman Islands’ special economic zone companies (SEZCos). The organisation, which applies the Theory of Change (TOC) methodology, provides Caymanians and residents with access to high-quality learning experiences and opportunities to develop and launch new business ventures, to pursue careers within the technology and innovation sectors, and to join a dynamic network of industry professionals. Let’s grow the next generation of Caymanian innovators and entrepreneurs with Enterprise Cayman!
Logo: https://mma.prnewswire.com/media/1317764/2860789/Cayman_Enterprise_City_Logo.jpg
FOR MORE INFORMATION:Contact: Kaitlyn Elphinstone Email: [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/cayman-enterprise-city-publishes-socio-economic-impact-assessment-by-economist-and-leading-advisor-on-the-caribbean-marla-dukharan-302148206.html
Artificial Intelligence
Strava Unveils New Chapter of Accelerated Product Development at Brand’s Flagship Event
The Company introduces increased product velocity, leveraging advancements in Artificial Intelligence, in service of its vision of a world connected through movement
LOS ANGELES, May 16, 2024 /PRNewswire/ — Strava, the leading digital community for active people with more than 125 million athletes, today showcased its latest initiatives and product developments at its annual event, Camp Strava. With the theme of Progress, Together company leaders announced how the platform will empower its global community to make progress in the way they explore, move, and connect on Strava.
“Strava is gaining momentum to realize our vision of a world connected through movement,” said Michael Martin, chief executive officer of Strava. “We are focused on two fundamental shifts to accelerate how we deliver value to 125 million people globally– building for women and leveraging Artificial Intelligence – which will unlock new community-and-partner-powered experiences across the platform.”
A New Era of Product VelocityStrava, with new leaders at the helm, is ushering in its next era of product velocity. The company listened closely to feedback from its global community and announced three of the most requested features coming to the platform by the end of the year.
The first of these updates, AI-enabled Leaderboard Integrity, will harness machine learning to automatically flag irregular, improbable, or impossible activities recorded to the platform. Trained by millions of activities, this feature allows all users on Strava to play fair and have more fun.
Additionally, the company announced a new Family Plan Subscription, the sister of the company’s Student Plan. With Family Plan, it’s easier to make a fitness commitment with your community by sharing an annual subscription with up to three other people – friends, family, or fitness family. Launching in select countries this summer, with plans to roll out globally by the end of the year, Strava’s newest annual subscription option offers the best value for groups (up to four), with a discount off the regular subscription price for each member.
Strava also implemented an updated design system, an initiative that is integral in driving a heightened pace of product innovation at the company. Through this work, Strava announced the launch of one of the company’s most requested features, Dark mode. Dark mode will improve the in-app experience for all users, reducing eye strain and improving accessibility while they record activity or scroll through the feed. Athletes can expect a rollout later this summer with options to keep their mobile settings always dark, always light, or match their device settings.
Company leaders highlighted several other features and updates to current products like Flyover, with its next iteration offering an overlay with activity stats and off-platform sharing capabilities. The overlay is available today for Strava subscribers and an off-platform sharing option will be released later this year.
Build for Her, Build for ManyStudies show that women of all ages participate in sports at a far lower rate than men, and overall, despite wanting to be active, find less time to dedicate to an active lifestyle. As the company continues on its mission to motivate people to live their best active lives, building for women on the platform will ultimately serve everyone in the Strava community. Several new features and initiatives were announced as a part of this strategic focus, which includes:
Night Heatmaps: Night Heatmaps show only activities between sundown and sunrise – so athletes can get an idea of which roads, trails, and paths are well-trafficked after hours. Since Night Heatmaps filter for after-hours routes, it can be a helpful tool for female athletes training before sunrise and after sunset.Quick Edit: For active women, having control over what is shared with the Strava community that cheers them on – like what time a run is logged – is important. Quick Edit makes it easier to make the most common edits – like activity name, and privacy settings so you can hide your start time, your map, or other workout stats.Strive for More®: The company announced a new phase of its Strive for More® initiative, created in 2022 to promote and support women in movement and sport. Today, Strava unveiled an official partnership with media company TOGETHXR to encourage more women to watch – and play – women’s sports. As part of the partnership, Strava will also donate $100,000 to the Alex Morgan Foundation, started by co-founder of TOGETHXR, Alex Morgan, to support their mission to help girls and women find confident paths forward in sports and life.Athlete IntelligenceToday, Strava announced the start of an accelerated product roadmap, outlining how Strava will implement the latest technological enhancements in AI and machine learning, to transform the athlete experience.
One key advancement to the platform includes the company’s latest development, Athlete Intelligence. Strava is introducing its beta AI-powered feature which turns each subscriber’s training data into an easily digestible summary that contextualizes their accomplishments and fitness goals. Unlike other AI-powered training services, Strava connects with thousands of devices, wearables, and fitness apps, so an athlete’s insights can consider their entire fitness story across multiple sports and modalities.
The features shared at Camp Strava will be released on a rolling basis through the end of the year. To view the full list of product releases and further details, visit www.press.strava.com.
For more information on Strava, to create a free account, or to start a free subscription trial visit www.strava.com.
About Strava Strava is the leading digital community for active people with more than 125 million athletes, in more than 190 countries. The platform offers a holistic view of your active lifestyle, no matter where you live, which sport you love and/or what device you use. Everyone belongs on Strava when they are pursuing an active life. Join the community, find motivation and discover new experiences with a Strava subscription.
Visit www.strava.com for more information and connect with Strava on Instagram, Twitter, Facebook, YouTube and LinkedIn.
Media Contact: [email protected]
Photo – https://mma.prnewswire.com/media/2413914/Darkmode_STRAVA.jpgPhoto – https://mma.prnewswire.com/media/2413915/Flyover_STRAVA.jpg Photo – https://mma.prnewswire.com/media/2413913/Athlete_Intelligence_STRAVA__INC.jpg
View original content:https://www.prnewswire.co.uk/news-releases/strava-unveils-new-chapter-of-accelerated-product-development-at-brands-flagship-event-302147068.html
Artificial Intelligence
Japan Data Center Market Investment to Reach $14.48 Billion by 2028 – Watch Out Exclusive Insight on Japan & Hong Kong Data Center Market – Arizton
CHICAGO, May 16, 2024 /PRNewswire/ — Arizton publishes the latest research report on the Japan data center market and Hong Kong data center market.
The Japan Data Center Market to Witness Investments of $14.48 Billion by 2029.
Get Insights on 107 Existing Data Centers and 41 Upcoming Facilities across Japan.
The data center market in Japan is experiencing the emergence of self-built hyperscale data center facilities by major operators such as Google, Microsoft, and Amazon Web Services (AWS). This development is expected to impact the colocation market in Japan. Since these hyperscale operators store workloads in their own data center facilities, it may reduce the source of revenue generation for colocation operators.
Japan is a well-established data center market in the APAC region. The country supports investments with its macroeconomic policies and other incentives for investors. The market is witnessing several investments from local and global data center operators, further expanding its presence. Tokyo and Osaka are Japan’s major destinations for data center development, accounting for over 90% of the existing data center facilities. The government announced the offer of subsidies in Hokkaido and Kyushu for data center development and decentralize data centers from Tokyo and Osaka.
Investment Opportunities
In October 2023, SoftBank and its subsidiary, IDC Frontier, announced the plan to develop a new data center facility in Tomakomai City, Hokkaido. The company invested around $420 million toward the project, for which it received subsidies worth $190 million from the Ministry of Economy, Trade, and Industry. In July 2023, Internet Initiative Japan (IIJ) launched its second data center building at the Shiroi data center campus in Chiba Prefecture, Greater Tokyo. Once fully built, the campus will house four data center buildings. Furthermore, the company is involved in a third expansion initiative in its Matsue City campus (which will likely go live in 2025).In June 2023, Digital Edge, in partnership with Hulic, a real estate developer, announced the start of the construction of a new data center facility, TY07, in Tokyo. The facility is expected to go online by 2025.In April 2024, GDS Services partnered with Gaw Capital to develop a new data center campus in Fuchu City, Tokyo. Both companies will jointly invest toward developing a new data center facility, with the first phase slated to go online by 2026.To Buy this Research Now, Click: https://www.arizton.com/market-reports/japan-data-center-market-investment-analysis
Existing Vs. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesList of Upcoming Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesVendor Analysis
IT Infrastructure Providers: Arista Networks, Atos, Broadcom, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Hitachi Vantara, Huawei Technologies, IBM, Inspur, Lenovo, NEC, NetApp, and Oracle.
Data Center Construction Contractors & Sub-Contractors: Arup, AECOM, Daiwa House Industry, Fuji Furukawa Engineering & Construction, Hibiya Engineering, ISG, Kajima Corporation, Keihanshin Building, Linesight, MARCAI DESIGN, Meiho Facility Works, Nikken Sekkei, NTT FACILITIES, Obayashi Corporation, SHINRYO Corporation, TAISEI Corporation.
Support Infrastructure Providers: 3M, ABB, Alfa Laval, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, HITEC Power Protection, Johnson Controls, Kawasaki Heavy Industries, KOHLSER-SDMO, Legrand, Mitsubishi Electric, Rittal, Rolls-Royce, Schneider Electric, STULZ, Siemens, Vertiv.
Data Center Investors: AirTrunk, Alibaba Cloud, Amazon Web Services, AT TOKYO, Colt Data Centre Services, Digital Edge, Equinix, Fujitsu, Goodman, Google, IDC Frontier, Internet Initiative Japan (IIJ), MC Digital Realty, Microsoft, NTT Communications, SCSK Corporation (NETXDC), Telehouse, Tencent Cloud, TIS INTEC Group.
New Entrants: Ada Infrastructure, Edge Centres, CyrusOne, ESR, GDS Services, Keppel Data Centres, NEXTDC, Princeton Digital Group (PDG), SC Zeus Data Center, STACK Infrastructure, ST Telemedia Global Data Centres, Vantage Data Centers, Yondr.
The Hong Kong Data Center Market will Witness Investments of $4.80 Billion by 2029.
Get Insights on 54 Existing Data Centers and 12 Upcoming Facilities across Hong Kong.
The Hong Kong data center market is booming, driven by the increasing demand for digital services. The data center investments in Hong Kong over the next two to three years are expected to remain high due to the surge in demand and the significant boost due to the advancements in AI technologies. Investors are actively investing in this market.
Hong Kong is a mature and thriving market for data center development in the APAC region. Investors find it an attractive market owing to the high internet and social media usage levels, a robust business ecosystem, and excellent connectivity through both inland and submarine cables. Additionally, the deployment of 5G technology further enhances its appeal.
Hong Kong stands out globally for the incredibly high rates of cell phone and home broadband service usage. With around 300 licensed internet service providers, there is robust competition, providing data center operators with a wide range of choices.
Hong Kong is considered an attractive destination for businesses due to various reasons. Its proximity to mainland China and its import-export relations with major markets, such as China and the US, make it easier for businesses to operate. Additionally, the market has experienced significant growth in Foreign Direct Investment (FDI), ranking after countries like the UK, the US, and China.
Investment Opportunities
In December 2023, the company completed the core and shell construction of phase-1 of the MEGA IDC data center campus. The facility has already signed lease agreements with cloud service providers and international banks for its available space. The company plans to expand the campus through phase-2 during the forecast period.In March 2023, the company launched its seventh data center facility, MEGA Gateway, in Tsuen Wan. The facility is part of its connected MEGA campus.Goodman is among the major investors in the Hong Kong market, and it is continuously expanding its data center presence. In March 2024, the company announced the construction of the new Texaco data center facility in Tsuen Wan. The facility is a brownfield construction that involved the conversion of an industrial building into a data center facility. The facility is likely to go online by 2026.Over 60% Of Future Demand to Come from Cloud Service Providers
The Hong Kong data center market has the presence of on-premises data centers operated by educational institutions, the government, and financial services such as HSBC Bank. A significant decline in on-premises data centers will occur in the next three to five years owing to the increase in digitalizing initiatives across sectors and the strong growth in demand for colocation and cloud services. In addition, most existing service providers offer managed solutions to enterprise customers, which will likely grow in the market from 2024-2029.
The market has the presence of all global cloud operators, such as Amazon Web Services (AWS), Google, Microsoft, Alibaba Cloud, Huawei Cloud, and Tencent Cloud. This will propel the demand for wholesale colocation services through these service providers’ continuous expansion initiatives. The cloud segments will likely dominate capacity take-up over the next five years. In addition, the market will witness the entry of multiple global organizations to service customers through a local presence.
To Buy this Research Now, Click: https://www.arizton.com/market-reports/hong-kong-data-center-market-size-analysis
Existing VS. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationList of Upcoming Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationVendor Analysis
IT Infrastructure Providers: Arista Network, Atos, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Huawei Technologies, IBM, Inspur, Lenovo, NetApp.
Data Center Construction Contractors & Sub-Contractors: Arup, AtkinsRéalis, Aurecon, BYME Engineering, Chung Hing Engineers Group, Cundall, DSCO Group, Gammon Construction, ISG, Studio One Design.
Support Infrastructure Providers: ABB, Airedale, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, KOHLER, Legrand, Mitsubishi Electric, Piller Power Systems, Rittal, Schneider Electric, Siemens, STULZ, Sumber, Vertiv.
Data Center Investors: AirTrunk, BDx, CITIC Telcom International, China Mobile International (CMI), China Unicom, Digital Realty, Equinix, ESR, GDS Services, Global Switch, Goodman, iTech Towers Data Centre Services, NTT DATA, SUNeVision Holdings (iAdvantage), Telehouse, Towngas Telecom (TGT), Vantage Data Centers.
New Entrants: Angelo Gordon and Mapletree Investments
Japan & Hong Kong Data Center Market Segmentation
IT Infrastructure
Servers
Storage Systems
Network Infrastructure
Electrical Infrastructure
UPS Systems
Generators
Transfer Switches & Switchgears
PDUs
Other Electrical Infrastructure
Mechanical Infrastructure
Cooling Systems
Rack Cabinets
Other Mechanical Infrastructure
Cooling Systems
CRAC & CRAH Units
Chiller Units
Cooling Towers, Condensers & Dry Coolers
Economizers & Evaporative Coolers
Other Cooling Units
General Construction
Core & Shell Development
Installation & Commissioning Services
Engineering & Building Design
Fire Detection & Suppression Systems
Physical Security
DCIM
Tier Standard
Tier I & Tier II
Tier III
Tier IV
Check Out Some of the Top Selling Research Reports:
Malaysia Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/malaysia-data-center-market-size-analysis
Singapore Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/singapore-data-center-market-size-analysis
Southeast Asia Data Center Construction Market – Industry Outlook & Forecast 2024-2029https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Why Arizton?
100% Customer Satisfaction
24×7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton’s report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us Call: +1-312-235-2040 +1 302 469 0707 Mail: [email protected] Contact Us: https://www.arizton.com/contact-us Blog: https://www.arizton.com/blog Website: https://www.arizton.com/
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/japan-data-center-market-investment-to-reach-14-48-billion-by-2028–watch-out-exclusive-insight-on-japan–hong-kong-data-center-market—arizton-302147784.html
-
Artificial Intelligence7 days agoSanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
-
Artificial Intelligence6 days agoIdentity Threat Detection and Response (ITDR) Market worth $35.6 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence7 days agoNorthern Data Group’s Peak Mining announces new partnership for 28MW of mining, powered by 100% renewable energy
-
Artificial Intelligence7 days ago
atNorth Shortlisted for Datacloud Global Awards, The Energy Awards and The Women in Green Business Awards
-
Artificial Intelligence6 days agoWIO Taps Gracenote to Revolutionize Television Broadcast Reporting
-
Artificial Intelligence7 days ago
Linnovate Partners Announces Close of USD 40 Million Funding Commitment Led by SeaTown
-
Artificial Intelligence7 days ago
CoreWeave Invests £1 Billion in UK; Opens New European Headquarters and Data Centres in London to Bring Cloud Infrastructure to Power the AI Revolution
-
Artificial Intelligence7 days agoProofID wins Judges’ Award for Global Ambition at the 2024 Northern Tech Awards
